新型免疫标志物IFI27可区分疑似呼吸道感染患者的流感与细菌感染
该研究整合1071例个体的基因组分析与体外感染模型,鉴定出单基因标志物IFI27,其预测准确率达91%,与多基因标志物相当。在439例未分化呼吸道疾病患者的前瞻性研究中,IFI27区分流感与细菌感染的诊断准确率(AUC)为88%,特异性为90%。IFI27有望克服基因组检测在临床应用的转化障碍。
要点
- IFI27单基因标志物诊断准确率91%,与多基因标志物相当。
- IFI27由TLR7在浆细胞样树突状细胞中上调,响应流感病毒而非细菌。
- 在未分化呼吸道疾病患者中,IFI27区分流感与细菌感染的AUC为88%,特异性90%。
核心结论
- IFI27是一种单基因免疫标志物,可高准确度区分流感与细菌感染,有望改善呼吸道感染的诊断与管理。
研究设计与样本
- 整合1071例个体的基因组分析与体外感染模型实验。
- 多个患者队列(n=521)的体内验证。
- 一项大型前瞻性研究(n=439)纳入未分化呼吸道疾病患者(病因包括病毒、细菌和非感染性疾病)。
主要发现
- IFI27预测准确率为91%,与多基因标志物相当。
- 体外实验显示IFI27由TLR7在浆细胞样树突状细胞中上调,该类抗原提呈细胞响应流感病毒而非细菌。
- 体内研究在多个患者队列(n=521)中证实IFI27在流感患者中表达,而细菌感染中不表达。
- 在未分化呼吸道疾病患者(n=439)中,IFI27区分流感与细菌感染的诊断准确率(AUC)为88%,特异性为90%。
关键数值与推荐
- IFI27预测准确率91%。
- IFI27区分流感与细菌感染的诊断准确率(AUC)88%,特异性90%。
临床怎么用
- IFI27作为单基因标志物,可能简化临床基因组检测流程,辅助鉴别流感与细菌感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Host response biomarkers can accurately distinguish between influenza and bacterial infection. However, published biomarkers require the measurement of many genes, thereby making it difficult to implement them in clinical practice. This study aims to identify a single-gene biomarker with a high diagnostic accuracy equivalent to multi-gene biomarkers.In this study, we combined an integrated genomic analysis of 1071 individuals with in vitro experiments using well-established infection models.We identified a single-gene biomarker, IFI27, which had a high prediction accuracy (91%) equivalent to that obtained by multi-gene biomarkers. In vitro studies showed that IFI27 was upregulated by TLR7 in plasmacytoid dendritic cells, antigen-presenting cells that responded to influenza virus rather than bacteria. In vivo studies confirmed that IFI27 was expressed in influenza patients but not in bacterial infection, as demonstrated in multiple patient cohorts (n=521). In a large prospective study (n=439) of patients presented with undifferentiated respiratory illness (aetiologies included viral, bacterial and non-infectious conditions), IFI27 displayed 88% diagnostic accuracy (AUC) and 90% specificity in discriminating between influenza and bacterial infections.IFI27 represents a significant step forward in overcoming a translational barrier in applying genomic assay in clinical setting; its implementation may improve the diagnosis and management of respiratory infection.
引用
- Tang BM, Shojaei M, Parnell GP, et al. A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection. Eur Respir J. 2017. PMID: 28619954. doi:10.1183/13993003.02098-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。